Riskpilot← Back to searchSign inGet full accessALGINOR PHARMA INGREDIENTS AS
ASActiveOrg 928521672Husøyvegen 260, 4262 AvaldsnesManufacture of pharmaceutical preparations · NACE 2120Est. 20220 employees
Revenue 2024
NOK 0
EBITDA margin
—
-476% vs 2023
Equity ratio
29.6%
Financial strength
Net profit 2024
NOK -228K
-348% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -317K | -476% |
| Net profit | NOK -228K | -348% |
| Total assets | NOK 33M | +76% |
| Equity | NOK 9,8M | -2% |
| Employees | 0 | — |
Legal name
ALGINOR PHARMA INGREDIENTS AS
Org number
928521672
Legal form
Aksjeselskap
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
11. januar 2022
Share capital
NOK 10 000 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap. Daglig leder og styrets leder i fellesskap.
Company purpose
Bedriftsrådgivning, forretningsutvikling, investering, forskning og utvikling, innovasjon, produksjon, handel og distribusjon.
Address
Husøyvegen 260, 4262 Avaldsnes
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 400 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 |
| EBITDA | 0 | −89 | −55 | −317 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | 0 | −89 | −55 | −317 |
| Net financials | 0 | 0 | 148 | 89 |
| Profit before tax | 0 | −89 | 93 | −228 |
| Tax | −0 | −0 | 1 | −0 |
| Net profit | 0 | −89 | 92 | −228 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 100 | 10 395 | 18 765 | 33 038 |
| Equity | 100 | 9 911 | 10 000 | 9 772 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 484 | 8 765 | 23 266 |
| Total debt | 0 | 484 | 8 765 | 23 266 |
EBITDA margin
-31709600.0%
This company
15.8%
Market median
-200693771% vs market
20212024
Equity ratio
29.6%
This company
38.2%
Market median
-23% vs market
20212024
Return on equity
-2.3%
This company
18.4%
Market median
-113% vs market
20212024
Net profit margin
-22825500.0%
This company
8.1%
Market median
-281796396% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
2.38×
This company
0.62×
Market median
-284% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SM Chief Executive Officer | Chief Executive Officer | 2026 |
| Former (1) | ||
HS Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2026 | |
| Chairman | 2026 | |
| Chairman | 2025 | |
| Board of Directors | 2026 | |
| Board of Directors | 2026 | |
| Former (7) | ||
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2022 – 2024 | |
| Chairman | 2023 – 2024 | |
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2023 – 2024 | |
| Chairman | 2024 – 2025 | |
| Board of Directors | 2024 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Alginor Asa
ALGINOR PHARMA INGREDIENTS AS Board members of ALGINOR PHARMA INGREDIENTS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Haakon Simonsen Farstadvoll | Chief Executive Officer | 0 companies |
| Steen Mylius Stricker Lund | Chief Executive Officer | 0 companies |
| Kristine Klaveness | Board of Directors | 0 companies |
| Torfinn Steinar Ege | Board of Directors | 0 companies |
| Benjamin Sannes Thormodsen | Board of Directors | 0 companies |
| Wenche Kjølås | Chairman | 0 companies |
| Thorleif Thormodsen | Chairman | 0 companies |
| Viggo Waagen | Board of Directors | 0 companies |
| Siv Gausdal Eriksen | Board of Directors | 0 companies |
| Sten Stenersen | Chairman | 0 companies |
| Kjetil Thormodsen Rein | Chairman | 0 companies |
| Lene Kili Apeland | Board of Directors | 0 companies |
| Gisle Løhre Johansen | Board of Directors | 0 companies |
| Per Arthur Sørlie | Board of Directors | 0 companies |